These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27127102)

  • 1. Gender difference in the response to valsartan/amlodipine single-pill combination in essential hypertension (China Status II): An observational study.
    Wang H; Chen H
    J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316643903. PubMed ID: 27127102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
    Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
    Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.
    Sison J; Vega RMR; Dayi H; Bader G; Brunel P
    Curr Med Res Opin; 2018 Mar; 34(3):501-515. PubMed ID: 29210288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness.
    Jatic Z; Skopljak A; Hebibovic S; Sukalo A; Rustempasic E; Valjevac A
    Med Arch; 2019 Jun; 73(3):157-162. PubMed ID: 31391706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study.
    Setiawati A; Kalim H; Abdillah A
    Acta Med Indones; 2015 Jul; 47(3):223-33. PubMed ID: 26586388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.
    Ahn Y; Kim Y; Chang K; Kim W; Rhee MY; Cha KS; Hyon MS; Shim CY; Lee SY; Kim DI; Kim SW; Lim SW; Han KR; Jo SH; Lee NH; Kwan J; Ahn T
    Medicine (Baltimore); 2018 Sep; 97(37):e12329. PubMed ID: 30212981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of valsartan/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study.
    Hu D; Liu L; Li W
    Adv Ther; 2014 Jul; 31(7):762-75. PubMed ID: 24985411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III).
    Huo Y; Gu Y; Ma G; Guo J; Xiong L; Luo Z; Xie J; Li W; Zhao J; Yan X; Liu W; Xu Y; Bao X; Zhao L; Yang M; Wang B; Iii Study Group TCS
    Curr Med Res Opin; 2019 Aug; 35(8):1441-1449. PubMed ID: 30880492
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of blood pressure reduction response and responder characteristics to fixed-dose combination treatment of amlodipine and losartan: a post hoc analysis of pooled clinical trials.
    Unniachan S; Wu D; Rajagopalan S; Hanson ME; Fujita KP
    J Clin Hypertens (Greenwich); 2014 Sep; 16(9):671-7. PubMed ID: 25098858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Braun N; Ulmer HJ; Ansari A; Handrock R; Klebs S
    Curr Med Res Opin; 2009 Feb; 25(2):421-30. PubMed ID: 19192987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
    Calhoun DA; Lacourcière Y; Crikelair N; Jia Y; Glazer RD
    Curr Med Res Opin; 2013 Aug; 29(8):901-10. PubMed ID: 23721363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).
    Motozato K; Miura S; Shiga Y; Kusumoto T; Adachi S; Inoue T; Fujisawa K; Saku K
    Clin Exp Hypertens; 2016; 38(1):45-50. PubMed ID: 26268636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.